TLR6 Gene

TLR6 - Toll-Like Receptor 6

Introduction

TLR6 (Toll-Like Receptor 6) is a pattern recognition receptor that plays critical roles in innate immunity and neuroinflammation. Encoded by the TLR6 gene located on chromosome 4p14, this protein functions primarily as a co-receptor with TLR2 for recognition of bacterial and fungal components. TLR6 has been increasingly recognized for its involvement in neuroinflammatory processes associated with neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and Multiple Sclerosis. [@takeuchi2001]

<div class="infobox infobox-gene"> [@walter2007]
<table> [@letiembre2007]
<tr><th colspan="2" style="background:#f0f0f0;">Gene Information</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>TLR6</td></tr>
<tr><td><strong>Full Name</strong></td><td>Toll-Like Receptor 6</td></tr>
<tr><td><strong>Chromosomal Location</strong></td><td>4p14</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>10333</td></tr>
<tr><td><strong>OMIM</strong></td><td>607209</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000174128</td></tr>
<tr><td><strong>UniProt</strong></td><td>Q9NYK5</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Atherosclerosis</td></tr>
</table>
</div>

Overview

TLR6 - Toll-Like Receptor 6

Introduction

TLR6 (Toll-Like Receptor 6) is a pattern recognition receptor that plays critical roles in innate immunity and neuroinflammation. Encoded by the TLR6 gene located on chromosome 4p14, this protein functions primarily as a co-receptor with TLR2 for recognition of bacterial and fungal components. TLR6 has been increasingly recognized for its involvement in neuroinflammatory processes associated with neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and Multiple Sclerosis. [@takeuchi2001]

<div class="infobox infobox-gene"> [@walter2007]
<table> [@letiembre2007]
<tr><th colspan="2" style="background:#f0f0f0;">Gene Information</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>TLR6</td></tr>
<tr><td><strong>Full Name</strong></td><td>Toll-Like Receptor 6</td></tr>
<tr><td><strong>Chromosomal Location</strong></td><td>4p14</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>10333</td></tr>
<tr><td><strong>OMIM</strong></td><td>607209</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000174128</td></tr>
<tr><td><strong>UniProt</strong></td><td>Q9NYK5</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Atherosclerosis</td></tr>
</table>
</div>

Overview

TLR6 encodes Toll-Like Receptor 6, a pattern recognition receptor that functions primarily as a co-receptor with TLR2 for recognition of bacterial and fungal components. TLR6 plays important roles in innate immunity and has been implicated in neuroinflammation associated with neurodegenerative diseases. The receptor recognizes diverse microbial and endogenous ligands, triggering pro-inflammatory signaling cascades that can contribute to chronic neuroinflammation in the aging brain.

Protein Structure

TLR6 is a type I transmembrane protein with characteristic Toll-like receptor architecture:

Extracellular Domain

• Leucine-rich repeats (LRRs): 20-25 LRR motifs for ligand recognition
• N-terminal signal peptide: Directs protein to cell membrane
• Ligand-binding pocket: Recognizes di-acylated lipoproteins

Transmembrane Domain

• Single pass membrane protein: Spans membrane once
• Leucine zipper motifs: Facilitate receptor dimerization

Intracellular Domain

• TIR domain (Toll/IL-1 Receptor): Approximately 200 amino acids
• Signaling platform: Recruits adaptor proteins MyD88 and MAL

Normal Function

TLR6 typically forms heterodimers with TLR2 to recognize a broad range of ligands:

Pattern Recognition

• Di-acylated lipoproteins: From Gram-positive bacteria
• Zymosan: Fungal cell wall component
• Peptidoglycan: Bacterial cell wall component
• Endogenous ligands: [Heat shock proteins](/entities/heat-shock-proteins), HMGB1

Signaling Pathways

Cellular Functions

• Microglial activation: Primary responder in brain
• Cytokine production: IL-1beta, TNF-alpha, IL-6
• Phagocytosis: Enhanced clearance of pathogens and debris
• T cell activation: Links innate to adaptive immunity

Expression Pattern

TLR6 is expressed in various cell types with highest expression in immune cells:

| Cell Type | Expression | Notes |
|----------|-----------|-------|
| [Microglia](/cell-types/microglia-neuroinflammation) | High | Primary immune cells in brain, key mediator of neuroinflammation |
| [Astrocytes](/entities/astrocytes) | Low-Moderate | May upregulate under stress conditions |
| [Neurons](/entities/neurons) | Very Low | Limited expression, may increase in disease |
| Peripheral Immune Cells | High | Monocytes, B cells, dendritic cells |
| Oligodendrocytes | Moderate | May contribute to demyelination in MS |

Role in Neuroinflammation

Microglial Activation

Cytokine and Chemokine Production

• Pro-inflammatory cytokines: IL-1beta, TNF-alpha, IL-6
• Chemokines: CCL2, CCL3, CXCL10
• Matrix metalloproteinases: MMP-3, MMP-9

Oxidative Stress

Disease Associations

Alzheimer's Disease

• Association: TLR6 variants may modify AD risk through altered inflammatory responses
• Mechanism: Recognition of amyloid-associated bacterial/fungal products, amplifying neuroinflammation
• Pathology: TLR6+ microglia surrounding amyloid plaques
• Evidence: Genetic studies link TLR6 polymorphisms to AD susceptibility

Parkinson's Disease

• Association: TLR6 signaling contributes to PD pathogenesis
• Mechanism: Microglial activation via TLR2/TLR6 heterodimers, leading to dopaminergic neuron death
• Evidence: Elevated TLR6 expression in PD substantia nigra

Multiple Sclerosis

• Association: TLR6 modulates MS disease course
• Mechanism: Regulation of autoimmune responses and demyelination
• Therapeutic potential: TLR6 modulators may reduce disease activity

Atherosclerosis

• Association: TLR6 involved in vascular inflammation
• Mechanism: Recognition of oxidized lipids, contributing to plaque formation

Therapeutic Targeting

TLR6 represents a potential therapeutic target for modulating neuroinflammation:

| Strategy | Approach | Status |
|----------|----------|--------|
| TLR6 Modulators | Synthetic ligands or antagonists | Research |
| Anti-inflammatory | Natural compounds (curcumin, resveratrol) | Preclinical |
| Combination Therapy | TLR2/TLR6 dual targeting | Investigational |
| Microglial inhibitors | Minocycline and derivatives | Clinical trials |

Challenges

• TLR6 has complex roles in both protective and pathological immunity
• Systemic inhibition may increase infection risk
• [Blood-brain barrier](/entities/blood-brain-barrier) penetration required for CNS targeting

Key Publications

See Also

• [TLR2](/genes/tlr2)
• [TLR4](/genes/tlr4)
• [Microglia](/cell-types/microglia)
• [Neuroinflammation](/mechanisms/neuroinflammation)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)

Background

The study of Tlr6 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
• [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
• [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data

References